Heart medtech in $40m raise to fund flagship project
SYDNEY: Anteris Technologies, the heart medtech where L1 Capital owns 16.9 per cent, launched a… read more
New C.E.O. appointed to ASX listed biotech entity
SYDNEY: Biotech company ImpediMed has confirmed the appointment of Parmjot Bains as managing director and… read more
Increase in people hospitalised with psychosis after medicinal cannabis
SYDNEY: Medicinal cannabis is causing harm to some patients, with doctors warning of a significant… read more
